Etiqueta de registo: 00254nam 2200025 450
001 2184148
003 http://id.bnportugal.gov.pt/bib/catbnp/2184148
100 ## $a20240916d2024 k y0pory01030103ba
101 0# $aeng$dpor
102 ## $aPT
105 ## $aa m 000yy
106 ## $ar
200 1# $aOral delivery of semaglutide through multifunctional FcRn-peptide targeting nanoparticles for treatment of type 2 diabetes mellitus$fSoraia Pinto$gorient. Bruno Filipe Carmelino Cardoso Sarmento, Hélder Almeida Santos
210 #9 $aPorto$c[S.n.],$d2024
215 ## $a[22], XXVI, 182 p.$cil.$d30 cm
328 #1 $aTese dout. Ciências Biomédicas, Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, 2024
675 ## $a616.379-008.6(043)$vBN$zpor$31225752
675 ## $a616-085(043)$vBN$zpor$3435124
700 #1 $aPinto,$bSoraia$31928778
702 #1 $aSarmento,$bBruno,$f1978-$4727$31391327
702 #1 $aAlmeida,$bHélder Lopo Alves dos Santos$4727$3260549
801 #0 $aPT$bBN$gRPC
966 ## $lBN$mFGMON$sS.A. 192376 V.$x1
971 ## $cjbeatriz$d20240916
972 ## $e0$z0$d20251205$vasantos
973 ## $cacosta$d20251127
975 ## $e0$d20251209$viquintas